Envista Holdings Corporation (NVST)
NYSE: NVST · IEX Real-Time Price · USD
-0.70 (-4.18%)
Jul 12, 2024, 4:00 PM EDT - Market closed

Company Description

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.

The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.

The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products.

It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands.

The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products.

This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals.

Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Envista Holdings Corporation
Envista Holdings logo
Country United States
IPO Date Sep 18, 2019
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 12,800
CEO Paul A. Keel

Contact Details

200 S. Kraemer Blvd., Bldg. E
Brea, California 92821
United States
Phone 714-817-5418
Website envistaco.com

Stock Details

Ticker Symbol NVST
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
IPO Price $22.00
CIK Code 0001757073
CUSIP Number 29415F104
ISIN Number US29415F1049
Employer ID 83-2206728
SIC Code 3843

Key Executives

Name Position
Amir Aghdaei President, Chief Executive Officer and Director
Mark E. Nance Senior Vice President, General Counsel and Secretary
Stephen Keller Vice President of Investor Relations and Principal Financial Officer
Faez Kaabi Vice President, Chief Accounting Officer and Corporate Controller
Andrew Chen Chief Information Officer
Juan Arbona Chief Compliance Officer
Mischa M. Reis Senior Vice President of Strategy and Corporate Development
Suraj Satpathy Chief Human Resources officer
Filippo Impieri Senior Vice President of Emerging Markets
Claudia Ortiz Senior Vice President of Regulatory Affairs and Quality Assurance

Latest SEC Filings

Date Type Title
Jun 21, 2024 144 Filing
Jun 13, 2024 11-K Annual report of employee stock purchase, savings and similar plans
May 30, 2024 SD Form - SD
May 30, 2024 8-K Current Report
May 24, 2024 8-K Current Report
May 1, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 1, 2024 10-Q Quarterly Report
May 1, 2024 8-K Current Report
Apr 15, 2024 8-K Current Report
Apr 8, 2024 ARS Filing